Researchers silence pain neurons in the mouse spinal cord with injections of botulinum toxins modified to bind to the neurons’ receptors.

Compared to other drugs, therapeutics given breakthrough status receive FDA approval on the basis of weaker trial evidence, a study finds.

The UK-based organization encourages public debate about the issue but does not recommend immediate policy change.

The adoption of machine-learning techniques to aid in diagnosis should be done with radiologists’ guidance.

The DNA-cutting enzyme used in the technique is not as precisely targeted as scientists had thought, and investors take notice.

In a longitudinal study, researchers find that elderly people with higher pressure were more likely to show signs of Alzheimer’s disease in brain tissue.

Levels of tau, amyloid-β 42, and IL-10 extracted from extracellular vesicles that started out in the brain were higher in military personal suffering head injuries compared with healthy soldiers.

Brief electroporation appears to make T cells more receptive to new genetic material, which could speed the development of immunotherapies.

Despite the treatment being given for only six weeks, the positive effects lasted for a year.